Halozyme Therapeutics (HALO) Tops Q1 EPS by 4c; FY Revenue Guidance Tops Views
Go back to Halozyme Therapeutics (HALO) Tops Q1 EPS by 4c; FY Revenue Guidance Tops Views| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 111.45 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $111.45 | 52 Week High | $18.39 | |||
| Open | $111.45 | 52 Week Low | $6.96 | |||
| Day High | $111.45 | P/E | N/A | |||
| Day Low | $111.45 | EPS | $-0.58 | |||
| Volume | 295 | |||||
